|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/86 | (2006.01) |
| C12N 15/113 | (2010.01) | ||
| C12N 15/09 | (2006.01) |
| (11) | Number of the document | 3596222 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18768395.8 |
| Date of filing the European patent application | 2018-03-16 | |
| (97) | Date of publication of the European application | 2020-01-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-12 |
| (46) | Date of publication of the claims translation | 2023-07-25 |
| (86) | Number | PCT/US2018/022881 |
| Date | 2018-03-16 |
| (87) | Number | WO 2018/170408 |
| Date | 2018-09-20 |
| (30) | Number | Date | Country code |
| 201762473148 P | 2017-03-17 | US |
| (72) |
RODINO-KLAPAC, Louise , US
MENDELL, Jerry, R. , US
|
| (73) |
Research Institute at Nationwide
Children's Hospital ,
700 Children's Drive, Columbus, Ohio 43205,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Raumeniui specifinis mikrodistrofino pristatymas adenoasocijuoto viruso vektoriaus dėka, skirtas raumenų distrofijai gydyti |
| ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MUSCLE SPECIFIC MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY |
| Payment date | Validity (years) | Amount | |
| 2026-02-23 | 9 | 208.00 EUR |
| 2027-03-16 |